1
00:00:02,550 --> 00:00:07,190
Thymosin beta-4 and TB-500 are often
mentioned together.

2
00:00:07,990 --> 00:00:11,270
Before following a healing claim, identify
the molecule.

3
00:00:11,930 --> 00:00:16,190
Full-length thymosin beta-4 contains 43
amino acids.

4
00:00:16,790 --> 00:00:19,210
It helps regulate actin, a protein

5
00:00:19,210 --> 00:00:21,850
involved in cell shape and movement.

6
00:00:22,650 --> 00:00:25,450
That biology explains research interest; it

7
00:00:25,450 --> 00:00:27,910
does not make every related preparation
equivalent.

8
00:00:28,850 --> 00:00:32,530
A 2012 analytical study identified an
acetylated

9
00:00:32,530 --> 00:00:38,390
seven-amino-acid fragment in material sold
as TB-500.

10
00:00:39,430 --> 00:00:42,170
The FDA also warns that this common

11
00:00:42,170 --> 00:00:45,010
name has been used for different
substances.

12
00:00:45,890 --> 00:00:48,370
A label alone cannot settle identity.

13
00:00:49,170 --> 00:00:52,710
Human research has tested a defined
thymosin beta-4

14
00:00:52,710 --> 00:00:57,270
eye formulation for neurotrophic
keratopathy, a disease

15
00:00:57,270 --> 00:01:00,110
in which the corneal surface struggles to
heal.

16
00:01:00,710 --> 00:01:05,950
In one randomized study, six of ten treated
participants had complete

17
00:01:05,950 --> 00:01:10,270
healing at four weeks, compared with one of
eight receiving placebo.

18
00:01:11,210 --> 00:01:13,730
The primary comparison had a P value

19
00:01:13,730 --> 00:01:20,230
of 0.0656, above the study's 0.05
threshold.

20
00:01:20,950 --> 00:01:23,470
Later follow-up favored treatment, but the

21
00:01:23,470 --> 00:01:26,510
small study still calls for careful
interpretation.

22
00:01:27,510 --> 00:01:31,130
Missing that threshold does not prove there
was no benefit.

23
00:01:31,130 --> 00:01:34,670
An eye formulation studied in a particular
disease

24
00:01:34,670 --> 00:01:37,750
does not establish the benefits or safety
of a

25
00:01:37,750 --> 00:01:41,410
different fragment used for muscle or
tendon recovery.

26
00:01:42,270 --> 00:01:44,490
The practical research habit is simple:

27
00:01:45,250 --> 00:01:50,170
match the molecule, formulation,
population, and endpoint.

28
00:01:50,910 --> 00:01:54,930
Keep promising biology connected to the
preparation actually tested.

29
00:01:55,970 --> 00:01:57,710
World Peptide Foundation.

30
00:01:57,710 --> 00:02:00,490
Peptides in 2.

31
00:02:01,010 --> 00:02:02,410
Every experience matters.